NCT01893528View on ClinicalTrials.gov

Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

June 30, 2013

Primary Completion Date

September 30, 2014

Study Completion Date

September 30, 2014

Conditions
Healthy Volunteers
Interventions
DRUG

REGN2009

OTHER

placebo

Trial Locations (2)

Unknown

Baltimore

Cincinnati

All Listed Sponsors
lead

Regeneron Pharmaceuticals

INDUSTRY

NCT01893528 - Study to Assess the Safety and Tolerability of Ascending Single Doses of REGN2009 in Healthy Volunteers | Biotech Hunter | Biotech Hunter